Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.
about
Retroviral superinfection resistance.In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brainHTLV-1-infected T cells contain a single integrated provirus in natural infectionReciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins.Dynamics of HIV-1 recombination in its natural target cells.Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus.Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-indEnv-independent protection induced by live, attenuated simian immunodeficiency virus vaccines.Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells.
P2860
Q24815564-E2C78E45-10C4-453D-8673-327F56123A8CQ33640317-1B98449F-59CB-4F05-AC55-84340EF9D0B3Q33641801-EB9DE012-89D9-4228-8728-926AA2FC1037Q33671675-108EFFF7-5C69-4F7F-85DE-001BF250EEF3Q33782866-3C7A9EE9-CDCC-4C83-9551-E7450D0CFB3AQ34233867-AFD92EDD-F915-465B-85F3-E6925B99E724Q36352523-5B68624F-6120-4B62-97C6-5F7CF00BBF56Q37058590-D878A840-6EBA-4D82-BFAF-D515DB41E922Q37356815-1768D211-5A0D-4839-B21C-ACAD46D66CC4Q39549352-AFB962C2-CC27-436A-AFCD-6215F64AF185Q39577563-E73E1B6C-A853-4116-90EE-3FCE2574854BQ39580963-91A44AB7-4F6F-4B23-87C6-D735C3F65DEBQ39595638-85890E7A-A61B-4EDE-99FE-F8FD8ACA17F8
P2860
Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Interference to human immunode ...... principal virus receptor, CD4.
@ast
Interference to human immunode ...... principal virus receptor, CD4.
@en
type
label
Interference to human immunode ...... principal virus receptor, CD4.
@ast
Interference to human immunode ...... principal virus receptor, CD4.
@en
prefLabel
Interference to human immunode ...... principal virus receptor, CD4.
@ast
Interference to human immunode ...... principal virus receptor, CD4.
@en
P2093
P2860
P1433
P1476
Interference to human immunode ...... principal virus receptor, CD4
@en
P2093
P2860
P304
P407
P577
1996-06-01T00:00:00Z